S
CERE

SignatureFD’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

SignatureFD’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-210
Closed -$8.59K – 3347
2024
Q2 		$8.59K Hold
210
– – ﹤0.01% 2340
2024
Q1 		$8.88K Hold
210
– – ﹤0.01% 2343
2023
Q4 		$8.9K Buy
+210
New +$6.03K ﹤0.01% 2309

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

SignatureFD's CERE Position: Q3 2024 in Review

SignatureFD sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 210 shares — an estimated $8.59K sold.

SignatureFD first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $8.9K in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • SignatureFD reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • SignatureFD sold 210 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $8.59K.
  • SignatureFD first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • SignatureFD's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $8.9K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on SignatureFD's 13F filing for Q3 2024, filed 21 Oct 2024.